[go: up one dir, main page]

WO2005035528A3 - Nouveaux composes triazoliques, leur procede de preparation et compositions pharmaceutiques les contenant - Google Patents

Nouveaux composes triazoliques, leur procede de preparation et compositions pharmaceutiques les contenant Download PDF

Info

Publication number
WO2005035528A3
WO2005035528A3 PCT/IB2004/003360 IB2004003360W WO2005035528A3 WO 2005035528 A3 WO2005035528 A3 WO 2005035528A3 IB 2004003360 W IB2004003360 W IB 2004003360W WO 2005035528 A3 WO2005035528 A3 WO 2005035528A3
Authority
WO
WIPO (PCT)
Prior art keywords
antibacterial agents
triazole derivatives
formula
relates
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2004/003360
Other languages
English (en)
Other versions
WO2005035528A2 (fr
Inventor
Selvakumar Natesan
Jagattaran Das
Mohamed Takhi
Sanjay Trehan
Javed Iqbal
Sitaram Kumar Magadi
Sreenivas Kandepu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Original Assignee
Dr Reddys Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd filed Critical Dr Reddys Laboratories Ltd
Publication of WO2005035528A2 publication Critical patent/WO2005035528A2/fr
Publication of WO2005035528A3 publication Critical patent/WO2005035528A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention se rapporte à de nouveaux composés triazoliques répondant à la formule (I), leurs précurseurs de médicament, leurs sels pharmaceutiquement acceptables, et leurs stéréoisomères. La présente invention se rapporte également à un procédé de préparation des nouveaux composés répondant à la formule (I).
PCT/IB2004/003360 2003-10-14 2004-10-14 Nouveaux composes triazoliques, leur procede de preparation et compositions pharmaceutiques les contenant Ceased WO2005035528A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN824CH2003 2003-10-14
IN824/CHE/2003 2003-10-14

Publications (2)

Publication Number Publication Date
WO2005035528A2 WO2005035528A2 (fr) 2005-04-21
WO2005035528A3 true WO2005035528A3 (fr) 2005-06-02

Family

ID=34430677

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2004/003360 Ceased WO2005035528A2 (fr) 2003-10-14 2004-10-14 Nouveaux composes triazoliques, leur procede de preparation et compositions pharmaceutiques les contenant

Country Status (1)

Country Link
WO (1) WO2005035528A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696352B2 (en) 2004-06-18 2010-04-13 Millennium Pharmaceuticals, Inc. Factor Xa inhibitors
JP5020073B2 (ja) 2004-06-18 2012-09-05 ミレニアム ファーマシューティカルズ インク． 第Ｘａ因子阻害剤
US20070060658A1 (en) * 2005-08-31 2007-03-15 Diaz David D Stabilization of organogels and hydrogels by azide-alkyne [3+2] cycloaddition
BRPI0711296A2 (pt) 2006-05-05 2011-08-23 Millennium Phamaceutical Inc inibidores de fator xa
WO2011051960A2 (fr) * 2009-09-25 2011-05-05 Cadila Healthcare Limited Procédé de préparation de dérivés de rapamycine
EP2513094B1 (fr) 2009-12-17 2015-12-16 Millennium Pharmaceuticals, Inc. Sels et formes cristallines d'inhibiteur de facteur xa
US8742120B2 (en) 2009-12-17 2014-06-03 Millennium Pharmaceuticals, Inc. Methods of preparing factor xa inhibitors and salts thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051819A2 (fr) * 2000-12-26 2002-07-04 Dr. Reddy's Laboratories Ltd. Composés hétérocycliques antibactériens, mode d'élaboration et compositions pharmaceutiques ainsi obtenues
WO2003059894A1 (fr) * 2002-01-18 2003-07-24 Dr.Reddy's Laboratories Ltd. Nouveaux composes antibacteriens, procede pour leur preparation et compositions pharmaceutiques contenant de tels composes

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051819A2 (fr) * 2000-12-26 2002-07-04 Dr. Reddy's Laboratories Ltd. Composés hétérocycliques antibactériens, mode d'élaboration et compositions pharmaceutiques ainsi obtenues
WO2003059894A1 (fr) * 2002-01-18 2003-07-24 Dr.Reddy's Laboratories Ltd. Nouveaux composes antibacteriens, procede pour leur preparation et compositions pharmaceutiques contenant de tels composes

Also Published As

Publication number Publication date
WO2005035528A2 (fr) 2005-04-21

Similar Documents

Publication Publication Date Title
WO2005082892A3 (fr) Nouveaux composes de triazole en tant qu'agents antibacteriens et compositions pharmaceutiques en contenant
WO2004062601A3 (fr) Agents antibacteriens
WO2002024632A3 (fr) Composants chimiques
WO2005046589A3 (fr) Sels de composes de quinolinone acceptables d'un point de vue pharmaceutique et presentant des proprietes pharmaceutiques ameliorees
CA2445306A1 (fr) Procede de preparation de derives de 9-deoxo-9a-aza-9a-homoerythromycine a substitues en 4''
TW200728307A (en) Novel spirochromanone derivatives
MXPA02003977A (es) Inhibidores de adhesion de celula mediada por al°2.
WO2006053255A3 (fr) Nouveaux derives de betuline, preparation de ces derives et utilisation de ces derives
WO2007009656A3 (fr) Nouveau derive de 1,4-benzothiazepine-1,1-dioxyde presentant des proprietes ameliorees, procede de fabrication, medicaments contenant ce compose et utilisation
BR0108893B1 (pt) composiÇço farmacÊutica contendo derivados de azetidina, composto derivado de azetidina, e, processo para a preparaÇço de compostos.
WO2005110410A3 (fr) Inhibiteurs de kinases en tant qu'agents therapeutiques
WO2008142720A3 (fr) Dérivés d'oxime quinazoline inhibiteurs des hsp90
WO2003082205A3 (fr) Composes et procedes
WO2007109578A3 (fr) Gamma lactames substitues en tant qu'agents therapeutiques
WO2007072158A3 (fr) Dérivés pyrimidiques destinés à traiter une croissance cellulaire anormale
WO2004091504A3 (fr) Analogues de quinobenzoxazine substitués
WO2006113509A3 (fr) Analogues de quinobenzoxazines et procedes d'utilisation de ceux-ci
WO2004096823A3 (fr) Nouveaux derives de ketolides
WO2001053257A3 (fr) Nouveaux composes hypolipidemiques et hypocholesterolemiques, leur procede de preparation, et compositions pharmaceutiques les contenant
CA2469592A1 (fr) Inhibiteurs de l'integrase du vih
NO20052074L (no) Substituerte benzoksazinoner og anvendelser derav.
WO2005003087A3 (fr) Composes nouveaux utiles comme agents anti-bacteriens
WO2003082192A3 (fr) Composes et procedes
WO2004111008A3 (fr) Utilisation d'un compose de formule i pour la preparation d'une composition pharmaceutique
WO2007017728A3 (fr) Nouveaux composes heterocycliques

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase